16
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TQ0116 | LY 3000328 | Cathepsin S inhibitor | Cysteine Protease |
LY 3000328 (Cathepsin S inhibitor) is a potent, highly selective Cathepsin S (Cat S) inhibitor (IC50s: 7.7 and 1.67 nM for hCat S and mCat S). | |||
T6015 | Cathepsin Inhibitor 1 | Cysteine Protease | |
Cathepsin Inhibitor 1 is an inhibitor of Cathepsin (L, L2, S, K, B) with pIC50 of 7.9, 6.7, 6.0, 5.5 and 5.2, respectively. | |||
T12051 | MIV-247 | Cysteine Protease | |
MIV-247 is a selective and potent inhibitor of cathepsin S (Kis 2.1, 4.2, and 7.5 nM for human, mouse, and wild monkey cathepsin S, respectively), which attenuates mechanical anomalies in preclinical models of neuropathi... | |||
T13288 | VBY-825 | Cysteine Protease | |
VBY-825 is a reversible inhibitor of cathepsin with high potency against cathepsins B, L, S and V. | |||
T16089 | MK-0674 | Cysteine Protease | |
MK-0674 is an orally available, selective and potent cathepsin K inhibitor (IC50: 0.4 nM) that inhibits Cat B, Cat F, Cat L, and Cat S. It can be used in metabolism-related diseases. | |||
T3695 | Pepstatin | Pepstatin A,Pepsin Inhibitor S 735A,Ahpatinin C | Amino Acids and Derivatives , Proteasome , HIV Protease , Autophagy |
Pepstatin (Pepsin Inhibitor S 735A) is a specific aspartic proteases inhibitor produced by actinomycetes, and inhibits the aspartic proteases cathepsin D, pepsin and renin. | |||
T1850 | Balicatib | AAE581 | Cysteine Protease |
Balicatib (AAE581) is a potent and selective inhibitor of cathepsin K, used in trials studying the treatment of osteoporosis. | |||
T11554 | Cathepsin Inhibitor 2 | Cysteine Protease | |
Cathepsin Inhibitor 2 is a potent Cathepsin S inhibitor (Ki: <20 nM). | |||
T35753 | Z-Phe-Tyr(tBu)-diazomethylketone | ||
Irreversible cathepsin L inhibitor which is ca 10'000 times more effective in inactivating cathepsin L than cathepsin S. | |||
T27661 | JNJ-10329670 | ||
JNJ 10329670 is a highly potent (Ki of approximately 30 nM), nonpeptidic, noncovalent inhibitor of human cathepsin S with immunosuppressive activity. | |||
T16474 | Petesicatib | Cysteine Protease | |
Petesicatib is an inhibitor of cathepsin S. Petesicatib used in the research of immune diseases. | |||
T16092 | L-873724 | Others | |
L-873724 inhibits bone resorption. L-873724 is an effective, selective, and reversible non-basic cathepsin K inhibitor (IC50s: 0.2, 178, 264, and 5239 nM for cathepsin K, cathepsin S, cathepsin L, cathepsin B, respective... | |||
T72569 | Cathepsin L/S-IN-1 | ||
Cathepsin L/S-IN-1, a dual inhibitor targeting Cathepsin L and Cathepsin S, exhibits potent and selective inhibition with IC50 values of 4.10 μM and 1.79 μM, respectively. Demonstrating significant antimetastatic and inv... | |||
T80739 | Z-FG-NHO-BzOME | ||
Z-FG-NHO-BzOME is a chemical compound functioning as a cysteine protease inhibitor, selectively targeting and inhibiting cathepsin B, cathepsin L, cathepsin S, and papain [1]. | |||
T73395 | ASPER-29 | ||
ASPER-29, an analog of Asperphenamate, acts as a dual inhibitor of cathepsin L and S, displaying inhibitory concentrations (IC50) of 6.03 μM and 5.02 μM, respectively. This compound is utilized in the study of cancer mig... | |||
T62494 | Cathepsin C-IN-5 | ||
Cathepsin C-IN-5 (compound SF38) is a potent, selective, and orally active inhibitor of Cathepsin C, demonstrating IC50 values of 59.9 nM for Cat C, and showing significantly lower potency against Cat L (4.26 µM), Cat S,... |